INVO Stock: Why The Price Increased

By Amit Chowdhry ● Oct 15, 2021
  • The stock price of Invo Bioscience Inc (NASDAQ: INVO) increased by over 11% yesterday. This is why it happened.

The stock price of Invo Bioscience Inc (NASDAQ: INVO) – a medical device company focused on commercializing the world’s only in vivo culture system (IVC) INVOcell – increased by over 11% yesterday. Investors are responding positively to INVO Bioscience announced November 1, 2021 as the grand opening date for the company’s INVO Center joint venture, based in Monterrey, Mexico.

The new center – named “Positib Fertility, an INVO Center” – will focus on patients in need of advanced fertility care utilizing the efficient, effective, and affordable INVOcell solution. And this becomes the first INVO Center in Mexico and follows the recent openings of INVO Centers in Birmingham, Alabama, and Atlanta, Georgia.

Positib Fertility (an INVO Center) is a partnership between INVO Bioscience and experienced reproductive specialist Dr. Francisco Arredondo, MD., MPH, and Dr. Ramiro Ramirez Gutierrez, MD. Dr. Arredondo was an early adopter of the INVOcell solution as he began offering IVC via the INVOcell to his patients at fertility clinics in San Antonio and Austin in 2016. And in 2017, due to the success in expanding the accessibility of infertility treatment to patients utilizing INVOcell, he decided to open a center where he would exclusively offer the INVOcell solution in McAllen, Texas. Dr. Arredondo had successfully sold his U.S.-based fertility clinics in 2019 and is now focused on bringing the INVOcell solution to Mexico.


“I am incredibly excited to announce the grand opening of the first INVO Center in Mexico, ‘Positib Fertility,’ focused on the providing patients with an effective and affordable infertility solution. As an early adopter of the truly remarkable INVOcell technology while practicing in the United States, I was able witness the joy that can be brought to so many families struggling with fertility. I look forward to bringing that same joy to the people of Monterrey and the surrounding areas by the opening of this first-of-its-kind clinic in Mexico.”

— Dr. Arredondo

“This is yet another milestone in the history of the company and the INVOcell solution as we announce the grand opening of our first INVO Center in Mexico. Drs. Arredondo and Ramirez are leaders in the fertility industry, and more importantly, are highly passionate and dedicated to helping the families in Mexico who struggle with infertility. This is an exciting time for the industry as we take yet another significant step forward to advance our core mission of improving access to advanced fertility services for the many patients around the world through the use of the INVOcell solution.”

— Steve Shum, CEO of INVO Bioscience

“For too long, advanced fertility services have been largely unattainable to a large segment of the global population due to industry capacity and cost. I look forward to the opening of Positib Fertility leveraging the INVOcell technology which solves these two critical challenges helping to achieve the goal of democratizing fertility services.”

— Ramiro Ramirez, MD, of Positib Fertility

Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.